DiaNova Technologies is a mission-driven medical technology start-up re-engineering insulin delivery from first principles. Founded by a Type 1 diabetic with first-hand experience of the limitations of traditional systems, we exist to reduce the daily friction, cognitive load and long-term burdens of insulin-dependent diabetes - without compromising safety or clinical outcomes.

Despite decades of incremental progress, insulin delivery remains constrained by a shared set of common limitations. Devices are often bulky, reservoir capacity remains restricted, algorithms remain rigid, usability is inconsistent. For too many, the technology intended to provide freedom still introduces complexity.